Clinical Trials Logo
  1. Home
  2. Attention Deficit Disorder
  3. NCT03662763

Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity — SPD503-315  

Attention Deficit Disorder Clinical Trial

Official title:
Phase 3,Double Blind,Placebo-controlled,Multicentre,Randomised-withdrawal,Long-term Maintenance of Efficacy&Safety Study of Extended-release Guanfacine Hydrochloride in Children/Adolescents Aged 6-17 With ADHD

Clinical Trial Summary

A study to evaluate the long term maintenance of efficacy of using Guanfacine Hydrochloride (SPD-503) for the treatment of ADHD in Children aged 6-17 years in Europe, Australia, Canada and the US.

Clinical Trial Description

The SPD503-315 clinical program has studied the efficacy, safety, and tolerability of this product in treating symptoms of ADHD in children and adolescents aged 6-17 through short-term, placebo-controlled studies and long-termn, open-label studies. This study will more rigorously assess the long-term maintenance of efficacy using a placebo-controlled, randomised-withdrawal design. To date, all of the completed studies conducted as part of the SPD503 proigram have enrolled subjects from the US. This study is designed to evaluate the long-term maintenance of efficacy of SPD503 for the treatment of ADHD in children aged 6-17 years in Europe, Australia, Canada and US. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03662763
Study type Interventional
Source Maastricht University Medical Center
Contact
Status Completed
Phase Phase 3
Start date September 2011
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01883817 - Effect of Omega-3 Fatty Acid on Cortical Function in ADHD Phase 3
Recruiting NCT01154686 - Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities N/A
Unknown status NCT01130467 - Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Phase 4
Completed NCT04577417 - Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD
Completed NCT03948607 - Neural Mechanisms of Attention Lapses in Adult ADHD
Completed NCT06064942 - Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT06030024 - Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder N/A
Completed NCT05096975 - Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT02062411 - A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder N/A
Completed NCT01000064 - Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits Phase 3
Completed NCT00048360 - Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Phase 3
Completed NCT00776737 - Studies of Measures of Attention N/A
Recruiting NCT05133284 - Effectiveness of a Therapeutic Education Program in Improving Quality of Life of Children With ADHD and Their Parents
Recruiting NCT05243186 - Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill Phase 2/Phase 3
Completed NCT02635035 - Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT Phase 2
Completed NCT01369459 - Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder Phase 1
Recruiting NCT05406414 - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems N/A
Not yet recruiting NCT06248229 - A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Phase 4